"Barotrauma in Admitted Covid-19 Cases - A Single Center Retrospective Study"
BARCOV
"Review of Barotrauma in Admitted Covid-19 Cases - A Single Center Retrospective Study From March 2020 Till April 2021."
1 other identifier
observational
251
1 country
1
Brief Summary
A retrospective study is planned to find out the incidence and association type of respiratory support with barotrauma in Covid-19 cases admitted in Sultan Qaboos University Hospital. As widely known, Covid-19 affects the respiratory system primarily and is the main cause of admission to hospital. Depending upon the severity, different levels of respiratory support are offered to the patients. Normally patients with viral/bacterial respiratory diseases have a low incidence of barotrauma. Since this disease is new and it has been observed that a significant number of covid-19 patients develop barotrauma, hence it is deemed worthwhile to investigate the matter. All the patients admitted to the ward, high dependency unit, and intensive care unit will be scanned and those who developed barotrauma (pneumothorax, surgical emphysema, pneumo-pericardium, and pneumo-mediastinum) will be studied in detail and analyzed. This review is expected to highlight the problem and etiology and we might be able to suggest a management strategy to deal with this problem.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 24, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2021
CompletedFirst Submitted
Initial submission to the registry
January 28, 2022
CompletedFirst Posted
Study publicly available on registry
January 31, 2022
CompletedJuly 10, 2024
July 1, 2024
5 months
January 28, 2022
July 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of Barotrauma in admitted Covid-19 cases
Incidence of Barotrauma in admitted Covid-19 cases between March 2020 till April 2021
1-102 days
Secondary Outcomes (3)
Association of factors with Barotrauma in admitted Covid-19 cases
1-102 days
Mortality with cases versus controls
1-102 days
Ventilation days of cases versus controls
1-65 days
Study Arms (2)
Cases
Admitted Covid-19 cases who developed Barotrauma
Controls
Admitted Covid-19 cases who did not develop Barotrauma, matched with Cases with respect to age and sex.
Eligibility Criteria
A total of 2159 Covid-19 PCR-positive patients were identified in consecutive participant sampling at the University hospital during the study period. Out of these 63 patients were found to develop barotrauma. Matched controls were identified and a total of 322 cases was scanned. 61 patients were discharged from the emergency department after initial treatment, 1 patient left against medical advice and 2 patients died before they could be admitted to the ward and 7 were shifted to other hospitals, and their follow-up was lost, hence a total of 251 patients were finally studied. 63 patients were "Cases" and 188 were "Controls" in the ratio of 1:3 cases: controls.
You may qualify if:
- All admitted adult patients with covid PCR positive result
- Those who developed barotrauma were labeled as "Cases" and those without barotrauma were "Controls".
You may not qualify if:
- Adult patients with covid PCR positive result who were discharged from Emergency department.
- Adult patients with covid PCR positive result who died or left against medical advice before admission to ward/ICU
- Adult patients with covid PCR positive result who were shifted to other hospitals and their follow up could not be completed.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sultan Qaboos University Hospital
Muscat, 123, Oman
Related Publications (4)
Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, Scarlata S, Agro FE. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020 Aug;288(2):192-206. doi: 10.1111/joim.13091. Epub 2020 May 13.
PMID: 32348588BACKGROUNDKanne JP, Bai H, Bernheim A, Chung M, Haramati LB, Kallmes DF, Little BP, Rubin GD, Sverzellati N. COVID-19 Imaging: What We Know Now and What Remains Unknown. Radiology. 2021 Jun;299(3):E262-E279. doi: 10.1148/radiol.2021204522. Epub 2021 Feb 9.
PMID: 33560192BACKGROUNDSupady A, Curtis JR, Abrams D, Lorusso R, Bein T, Boldt J, Brown CE, Duerschmied D, Metaxa V, Brodie D. Allocating scarce intensive care resources during the COVID-19 pandemic: practical challenges to theoretical frameworks. Lancet Respir Med. 2021 Apr;9(4):430-434. doi: 10.1016/S2213-2600(20)30580-4. Epub 2021 Jan 12.
PMID: 33450202BACKGROUNDElhakim TS, Abdul HS, Pelaez Romero C, Rodriguez-Fuentes Y. Spontaneous pneumomediastinum, pneumothorax and subcutaneous emphysema in COVID-19 pneumonia: a rare case and literature review. BMJ Case Rep. 2020 Dec 12;13(12):e239489. doi: 10.1136/bcr-2020-239489.
PMID: 33310838BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jyoti Burad
Sultan Qaboos University Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior specialist
Study Record Dates
First Submitted
January 28, 2022
First Posted
January 31, 2022
Study Start
June 24, 2021
Primary Completion
November 30, 2021
Study Completion
November 30, 2021
Last Updated
July 10, 2024
Record last verified: 2024-07